Eva Maria Grossjohann

Eva Maria Grossjohann has four years of work experience. From 2022 to present, they have been a Senior Research Associate at Cimeio Therapeutics. From 2018 to 2022, they were a Senior Research Associate and Research Associate at Roche. From 2017 to 2018, they were a Research Assistant at CellGenix GmbH. From 2016 to 2017, they completed a Master Thesis Oncology/ Immunology at Universitätsklinikum Hamburg Eppendorf.

Eva Maria Grossjohann obtained a Master of Science (M.Sc.) in Molecular Life Sciences from the University of Hamburg between 2014 and 2017.